Biomarkers in Samples From Patients With Endometrial Cancer

Withdrawn before enrolling

Conditions studied: Lynch Syndrome, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer

In brief

This research study is studying biomarkers in samples from patients with endometrial cancer. Studying samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

Key facts

Study ID

NCT01199250

Run by

Gynecologic Oncology Group

People needed

0

Starts

2010-01-01

Expected to finish

2019-05-01

Last updated by the study team

2024-08-14

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Samples available from one of the following:
• GOG-0210
• Washington University School of Medicine Siteman Cancer Center

Where it is running

• Gynecologic Oncology Group — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.